Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tumor microbial burden drives immune responses through regulation of Interferon signaling.

Cancer discovery·2026
Same author

Glycoprotein mucin 13 expression as a theranostic target in colorectal cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

EXONERATE-TRaCE: A Liquid Biopsy for Tracking Response to Anti-Epidermal Growth Factor Receptor-Based Therapy in Metastatic Colorectal Cancer.

JCO precision oncology·2026
Same author

Reprogramming of Cellular Plasticity via ETS and MYC Core-regulatory Circuits During Response to MAPK Inhibition in BRAF-mutant Colorectal Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

BI 905711, a TRAILR2/CDH17 Bispecific Antibody, Alone or with Chemotherapy for Patients with Advanced Gastrointestinal Cancers: Phase I Study Findings.

Cancer research communications·2026
Same author

Genomic analysis of T Cell receptors reveals lynch syndrome specific immune signatures.

Nature communications·2026

Related Experiment Video

Updated: Feb 26, 2026

A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer
06:01

A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer

Published on: July 6, 2017

10.0K

Streptococcus gallolyticus subsp. gallolyticus promotes colorectal tumor development.

Ritesh Kumar1, Jennifer L Herold1, Deborah Schady2

  • 1Center for Infectious and Inflammatory Diseases, Institute of Biosciences and Technology, Texas A&M Health Science Center, Houston, Texas, United States of America.

Plos Pathogens
|July 14, 2017
PubMed
Summary

Streptococcus gallolyticus subsp. gallolyticus (Sg) promotes colorectal cancer (CRC) development by increasing cell proliferation and tumor burden. This bacterium is frequently found in CRC patients, highlighting its clinical significance.

More Related Videos

Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice
09:01

Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice

Published on: March 10, 2015

10.6K
Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer
06:24

Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer

Published on: October 13, 2023

1.7K

Related Experiment Videos

Last Updated: Feb 26, 2026

A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer
06:01

A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer

Published on: July 6, 2017

10.0K
Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice
09:01

Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice

Published on: March 10, 2015

10.6K
Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer
06:24

Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer

Published on: October 13, 2023

1.7K

Area of Science:

  • Microbiology
  • Oncology
  • Gastroenterology

Background:

  • Streptococcus gallolyticus subsp. gallolyticus (Sg) shows a strong association with colorectal cancer (CRC).
  • The precise role of Sg in CRC pathogenesis remains largely unelucidated.
  • Understanding Sg's contribution to CRC is crucial for clinical management.

Purpose of the Study:

  • To investigate the role of Sg in the development and progression of colorectal cancer.
  • To elucidate the mechanisms by which Sg influences colon cancer cell behavior.
  • To determine the prevalence and association of Sg in human CRC tissues.

Main Methods:

  • In vitro experiments assessing Sg's effect on human colon cancer cell proliferation.
  • Analysis of key molecular markers (β-catenin, c-Myc, PCNA) in Sg-treated cells.
  • In vivo mouse models to evaluate Sg's impact on tumor formation and progression.
  • Detection of Sg in patient-derived tumor and normal tissues.

Main Results:

  • Sg significantly enhances colon cancer cell proliferation, dependent on bacterial growth phase and direct contact.
  • Sg increases levels of β-catenin, c-Myc, and PCNA; β-catenin inhibition abrogates Sg's effect.
  • Sg administration in mice led to increased tumor incidence, burden, dysplasia, and proliferation.
  • Sg was detected in the majority of CRC patient samples and preferentially associated with tumor tissues.

Conclusions:

  • Sg actively promotes colorectal cancer development and progression.
  • The tumor-promoting role of Sg involves the β-catenin signaling pathway and direct bacterial-host interaction.
  • Sg represents a significant factor in CRC pathogenesis with potential clinical implications for diagnosis and treatment.